B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ergoloid Mesylates

32 PubMed studies analyzed · 3 RCTs · Evidence Score: 44.8

Research Domains

Ergoloid Mesylates has been studied across 12 research domains including 🧠 Neuroprotection, 🧠 Cognitive, ❤️ Cardiovascular, 🌤️ Mood & Depression, ⏳ Longevity & Aging. The primary research focus is 🧠 Neuroprotection with 59% of studies addressing this area.

Loading evidence profile...

This evidence profile for Ergoloid Mesylates is generated deterministically from 32 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.